Literature DB >> 22612467

Vascular endothelial growth factor -634G/C polymorphism associated with osteonecrosis of the femoral head in a Chinese population.

Bin Liu1, Yang Cao, Dawei Wang, Guijun Yao, Zhenggang Bi.   

Abstract

An impeded blood flow through the femoral head is incriminated in the etiopathogenesis of osteonecrosis of the femoral head (ONFH). Vascular endothelial growth factor (VEGF) is a strong angiogenic protein and also plays a role in the formation of cartilage and bone. The aim of this study was to evaluate the association of VEGF -634G/C polymorphism with ONFH in a Chinese population. A total of 220 unrelated patients with nontraumatic ONFH and 220 unrelated control subjects were consecutively enrolled in a hospital-based case-control study. A polymerase chain reaction-restriction fragment length polymorphism analysis was used to detect the VEGF -634G/C genotype. Patients with ONFH had a significantly higher frequency of the CC genotype (odds ratio=1.64, 95% confidence interval=1.03, 2.60; p=0.04) than controls. There were no significant associations between any genotypes and the cause of ONFH. Our results support the hypothesis that the VEGF -634CC genotype is a risk factor of ONFH in the Chinese population. However, current results should be validated prospectively in larger cohorts.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22612467     DOI: 10.1089/gtmb.2011.0384

Source DB:  PubMed          Journal:  Genet Test Mol Biomarkers        ISSN: 1945-0257


  10 in total

1.  Association between VEGF -634G/C polymorphism and osteonecrosis of the femoral head susceptibility: a meta analysis.

Authors:  Yaosheng Liu; Zhicheng Zhang; Shubin Liu; Xiuyun Su; Shiguo Zhou
Journal:  Int J Clin Exp Med       Date:  2015-07-15

2.  CORR Insights®: Free Vascularized Fibular Grafting Improves Vascularity Compared With Core Decompression in Femoral Head Osteonecrosis: A Randomized Clinical Trial.

Authors:  Anton Plakseychuk
Journal:  Clin Orthop Relat Res       Date:  2017-06-22       Impact factor: 4.176

3.  Association between vascular endothelial growth factor gene polymorphisms and the risk of osteonecrosis of the femoral head: Systematic review.

Authors:  Guo Ju Hong; Nuan Lin; Lei Lei Chen; Xiao Bo Chen; Wei He
Journal:  Biomed Rep       Date:  2015-10-06

Review 4.  Association of Specific Genetic Polymorphisms with Atraumatic Osteonecrosis of the Femoral Head: A Narrative Review.

Authors:  Prasoon Kumar; Pratik M Rathod; Sameer Aggarwal; Sandeep Patel; Vishal Kumar; Karan Jindal
Journal:  Indian J Orthop       Date:  2022-01-06       Impact factor: 1.033

5.  The association between VEGF -634C/G polymorphisms and osteonecrosis of femoral head: a meta-analysis.

Authors:  Yao Wang; Chong-Jun Xia; Beng-Jie Wang; Xiao-Wei Ma; De-Wei Zhao
Journal:  Int J Clin Exp Med       Date:  2015-06-15

6.  Relation between osteonecrosis of the femoral head and PAI-1 4G/5G gene polymorphism: a meta-analysis.

Authors:  Zheng Zeng; Bing Wang; Haitao Pan
Journal:  Int J Clin Exp Med       Date:  2015-11-15

7.  Cajan leaf combined with bone marrow-derived mesenchymal stem cells for the treatment of osteonecrosis of the femoral head.

Authors:  DA Shi; Yindi Sun; Jichao Yin; Xiaochen Fan; Honghao Duan; Na Liu; Wei He
Journal:  Exp Ther Med       Date:  2014-03-14       Impact factor: 2.447

8.  Bone vascularization in normal and disease conditions.

Authors:  Christian Carulli; Massimo Innocenti; Maria Luisa Brandi
Journal:  Front Endocrinol (Lausanne)       Date:  2013-08-26       Impact factor: 5.555

9.  An association study between hypoxia inducible factor-1alpha (HIF-1α) polymorphisms and osteonecrosis.

Authors:  Georgia Chachami; Alkmini Kalousi; Loukia Papatheodorou; Aggeliki Lyberopoulou; Vasileios Nasikas; Keiji Tanimoto; George Simos; Konstantinos N Malizos; Eleni Georgatsou
Journal:  PLoS One       Date:  2013-11-18       Impact factor: 3.240

10.  Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study.

Authors:  Wenlong Ma; Kun Xin; Ke Chen; Hongtao Tang; Honggan Chen; Liqiang Zhi; Hongliang Liu
Journal:  Sci Rep       Date:  2018-11-01       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.